Home
News
News
Cannabis drug gets approval in Spain
The Spanish Ministry for Health has announced the authorisation of the sale of GW Pharmaceuticals drug ‘Sativex’ in Spain. The drug contains a cannabis derivative and is used for the treatment of muscular spasms in multiple sclerosis sufferers. It is applied via an oral spray.
Minister for Health, Trinidad Jiménez, ruled out widening the use of the drug to other patients, such as cancer sufferers for example.
Before it appears in the chemist the drug has to have a price approved by the Ministry, and the drug will then be sold across Europe, except in the U.K. by the Almirall S.A. Company. GW Pharmaceuticals is awaiting approval for its use in Germany, France and Italy. It was approved for use in the U.K.in June 2010.
Minister for Health, Trinidad Jiménez, ruled out widening the use of the drug to other patients, such as cancer sufferers for example.
Before it appears in the chemist the drug has to have a price approved by the Ministry, and the drug will then be sold across Europe, except in the U.K. by the Almirall S.A. Company. GW Pharmaceuticals is awaiting approval for its use in Germany, France and Italy. It was approved for use in the U.K.in June 2010.
(You can find a photo for this story at Typically Spanish - Click here)